Sogo Nishimoto Selected Research

Neoplasms (Cancer)

4/2012

Nobiletin suppresses adipocyte differentiation of 3T3-L1 cells by an insulin and IBMX mixture induction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sogo Nishimoto Research Topics

Disease

1	Leukemia 04/2019
1	Carcinoma (Carcinomatosis) 01/2013
1	Atrophy 01/2013
1	Neoplasms (Cancer) 04/2012
1	Body Weight (Weight, Body) 01/2012
1	Obesity 01/2012
1	Weight Loss (Weight Reduction) 01/2012
1	Cataract (Cataracts) 08/2003

Drug/Important Bio-Agent (IBA)

1	AntigensIBA 04/2019
1	2-phenylphenol (orthophenylphenol)IBA 01/2013
1	nobiletinIBA 04/2012
1	AdiponectinIBA 01/2012
1	secoisolariciresinolIBA 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 08/2003

Therapy/Procedure

2	Oral Administration 01/2012 - 01/2012
1	Subcutaneous Injections 01/2012